These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6069848)

  • 81. [The pathogenetic problem of phenylpyruvic oligophrenia].
    Cumer Bruno S; Bruno A
    Riv Neurobiol; 1966; 12(4):529-88. PubMed ID: 5994783
    [No Abstract]   [Full Text] [Related]  

  • 82. Atypical phenylketonuria in a seven-year-old profoundly retarded girl: development of phenylalanine tolerance, in spite of apparently continued failure to convert phenylalanine to tyrosine.
    Cohn GH; Ouellette EM; Moser HW; Efron ML
    Neurology; 1968 Mar; 18(3):310-1. PubMed ID: 5690427
    [No Abstract]   [Full Text] [Related]  

  • 83. Biochemical factors in mental retardation.
    Hsia DY
    Proc Annu Meet Am Psychopathol Assoc; 1967; 56():28-44. PubMed ID: 4966303
    [No Abstract]   [Full Text] [Related]  

  • 84. A synopsis of the unconjugated acidic transamination metabolites of phenylalanine in phenylketonuria.
    Langenbeck U; Behbehani A; Mench-Hoinowski A
    J Inherit Metab Dis; 1992; 15(1):136-44. PubMed ID: 1583868
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Control of pyruvate and beta-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease.
    Land JM; Mowbray J; Clark JB
    J Neurochem; 1976 Apr; 26(4):823-30. PubMed ID: 987160
    [No Abstract]   [Full Text] [Related]  

  • 86. Phenylketonuria or phenylpyruvic oligophrenia in the rat: behavioural and biochemical correlates.
    Perez VJ
    J Ment Defic Res; 1965 Sep; 9(3):170-82. PubMed ID: 5892858
    [No Abstract]   [Full Text] [Related]  

  • 87. Inhibition of human brain pyruvate kinase and hexokinase by phenylalanine and phenylpyruvate: possible relevance to phenylketonuric brain damage.
    Weber G
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1365-9. PubMed ID: 5260939
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Phenylalanine metabolism in the phenylpyruvic condition. I. Distribution, pool size, and turnover rate in human phenylketonuria.
    GRUMER HD; KOBLET H; WOODARD C
    J Clin Invest; 1961 Sep; 40(9):1758-65. PubMed ID: 13709234
    [No Abstract]   [Full Text] [Related]  

  • 89. Hyperphenylalaninemia: disaggregation of brain polyribosomes in young rats.
    Aoki K; Siegel FL
    Science; 1970 Apr; 168(3927):129-30. PubMed ID: 5461364
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The origin of urinary p-hydroxyphenylpyruvate in a patient with hepatic cytosol tyrosine aminotransferase deficiency.
    Kennaway NG; Buist NR; Fellman JH
    Clin Chim Acta; 1972 Oct; 41():157-61. PubMed ID: 4405100
    [No Abstract]   [Full Text] [Related]  

  • 91. Hyperaminoacidemia effects on intestinal transport of related amino acids.
    Wapnir RA; Hawkins RL; Lifshitz F
    Am J Physiol; 1972 Oct; 223(4):788-93. PubMed ID: 4263024
    [No Abstract]   [Full Text] [Related]  

  • 92. Phenylalanine loading and aromatic acid excretion in normal subjects and heterozygotes for phenylketonuria.
    Blau K; Summer GK; Newsome HC; Edwards CH
    Clin Chim Acta; 1973 May; 45(3):197-205. PubMed ID: 4708049
    [No Abstract]   [Full Text] [Related]  

  • 93. Inhibition of protein and aminoacyl-tRNA synthesis, and binding and transport sites for aromatic amino acids in the brain in vitro with aromatic acids.
    Lähdesmäki P
    Int J Neurosci; 1984 Mar; 23(1):1-13. PubMed ID: 6563016
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Tyrosine toxicity in the rat: effect of high intake of p-hydroxyphenylpyruvic acid and of force-feeding high tyrosine diet.
    Boctor AM; Harper AE
    J Nutr; 1968 Aug; 95(4):535-40. PubMed ID: 4385833
    [No Abstract]   [Full Text] [Related]  

  • 95. The regulation of phenylalanine hydroxylase in rat tissues in vivo. The maintenance of high plasma phenylalanine concentrations in suckling rats: a model for phenylketonuria.
    Delvalle JA; Greengard O
    Biochem J; 1976 Mar; 154(3):613-8. PubMed ID: 133670
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Identification of heterozygotes with phenylketonuria on basis of blood tyrosine responses.
    ANDERSON JA; GRAVEM H; ERTEL R; FISCH R
    J Pediatr; 1962 Oct; 61():603-9. PubMed ID: 13861239
    [No Abstract]   [Full Text] [Related]  

  • 97. Enduring behavioral changes in rats with experimental phenylketonuria.
    Andersen AE; Guroff G
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):863-7. PubMed ID: 4260277
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Phenylalanine metabolites, attention span and hyperactivity.
    Michals K; Matalon R
    Am J Clin Nutr; 1985 Aug; 42(2):361-5. PubMed ID: 4025205
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The dietary phenylalanine requirements and tolerances of phenylketonuric patients.
    PAINE RS; HSIA DY
    AMA J Dis Child; 1957 Sep; 94(3):224-30. PubMed ID: 13457650
    [No Abstract]   [Full Text] [Related]  

  • 100. Influence of anabolic hormones on phenylalanine metabolism. II. Studies in animals.
    Reiss M; Sideman MB; Plichita ES
    J Ment Defic Res; 1966 Jun; 10(2):130-40. PubMed ID: 5962002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.